Zai Lab Ltd (23) | Business Operations (5)
Browse by Subcategory
Recent Contracts
-
License and Collaboration Agreement by and between Zai Lab (Shanghai) Co., Ltd. and Blueprint Medicines Corporation, dated November 8, 2021
(Filed With SEC on March 1, 2022)
-
Collaboration and License Agreement, dated as of May 28, 2021, by and between Zai Lab (Hong Kong) Limited and Mirati Therapeutics, Inc
(Filed With SEC on August 9, 2021)
-
License and Collaboration Agreement, dated as of June 15, 2021, by and between Zai Lab (US) LLC and MacroGenics, Inc
(Filed With SEC on August 9, 2021)
-
Collaboration and License Agreement between argenx BV and Zai Auto Immune (Hong Kong) Limited dated January 6, 2021
(Filed With SEC on May 10, 2021)
-
Collaboration Agreement between Regeneron Ireland Designated Activity Company and Zai Lab (Shanghai) Co., Ltd. dated April 6, 2020
(Filed With SEC on March 1, 2021)